A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia

Blood

Volumn 117, Issue 25, 2011, Pages 6906-6911

  Kim, Dong Hwan ^a,b   Lee, Seung Tae ^a   Won, Hong Hee ^c,d   Kim, Seonwoo ^c   Kim, Min Ji ^c   Kim, Hee Jin ^a   Kim, Sun Hee ^a   Kim, Jong Won ^a   Kim, Hyeoung Joon ^e   Kim, Yeo Kyeoung ^e   Sohn, Sang Kyun ^f   Moon, Joon Ho ^f   Jung, Chul Won ^a   Lipton, Jeffrey H ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b UNIVERSITY OF TORONTO   (Canada)

^c Samsung Medical Center   (South Korea)

^d Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^e Chonnam National University Hwasun Hospital and Medical School   (South Korea)

^f Kyungpook National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AKAP12 GENE; ARTICLE; CHROMOSOME 17P; CHROMOSOME 6Q; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; KOREA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RMND1 GENE; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS; WSB1 GENE; ZBTB2 GENE;

EID: 79959531969     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-01-329797     Document Type: Article

References (19)

1. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2008;40(10):1204-1210.
2. Crowther-Swanepoel D, Broderick P, Di Bernardo MC, et al. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet. 2010;42(2):132-136.
3. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009;41(9):1006-1010.
4. Sherborne AL, Hosking FJ, Prasad RB, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet. 2010;42(6):492-494.
5. Prasad RB, Hosking FJ, Vijayakrishnan J, et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood. 2010;115(9):1765-1767.
6. Knight JA, Skol AD, Shinde A, et al. Genomewide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility. Blood. 2009;113(22):5575-5582.
7. Kim DH, Xu W, Ma C, et al. Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia. Blood. 2009;113(11):2517-2525.
8. Price AL, Zaitlen NA, Reich D, Patterson N. New approaches to population stratification in genome-wide association studies. Nat Rev Genet. 2010;11(7):459-463.
9. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population- based linkage analyses. Am J Hum Genet. 2007;81(3):559-575. (Pubitemid 47330214)
10. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263-265. (Pubitemid 40202029)
11. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5(6):e1000529.
12. Zheng W, Long J, Gao YT, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009;41(3):324-328.
13. Jeon BN, Choi WI, Yu MY, et al. ZBTB2, a novel master regulator of the p53 pathway. J Biol Chem. 2009;284(27):17935-17946.
14. Boultwood J, Pellagatti A, Watkins F, et al. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol. 2004;126(4):508-511. (Pubitemid 39093092)
15. Choi MC, Jong HS, Kim TY, et al. AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene. 2004;23(42):7095-7103. (Pubitemid 39319171)
16. Choi DW, Seo YM, Kim EA, et al. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1. J Biol Chem. 2008;283(8):4682-4689.
17. Dentice M, Bandyopadhyay A, Gereben B, et al. The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat Cell Biol. 2005;7(7):698-705. (Pubitemid 40975751)
18. Chen QR, Bilke S, Wei JS, et al. Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma. Genes Chromosomes Cancer. 2006;45(9):856-862. (Pubitemid 44182444)
19. Archange C, Nowak J, Garcia S, et al. The WSB1 gene is involved in pancreatic cancer progression. PLoS ONE. 2008;3(6):e2475.